Zydus Cadila arm to sell 2 brands Mifegest, Cytolog to Integrace

Published On 2021-09-22 09:00 GMT   |   Update On 2021-09-22 09:00 GMT

Ahmedabad: Zydus Healthcare Limited, a wholly owned subsidiary of Zydus Cadila has announced that the company has entered into an agreement with Integrace Private Limited ("Purchaser") to sell two brands viz. Mifegest and Cytolog.The companies have entered into an agreement on September 20, 2021."The said transaction is expected to be completed within 30 days from the date of...

Login or Register to read the full article

Ahmedabad: Zydus Healthcare Limited, a wholly owned subsidiary of Zydus Cadila has announced that the company has entered into an agreement with Integrace Private Limited ("Purchaser") to sell two brands viz. Mifegest and Cytolog.

The companies have entered into an agreement on September 20, 2021.

"The said transaction is expected to be completed within 30 days from the date of execution of agreement subject to customary approvals," the company said in a BSE filing.

Integrace is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.

Read also: Zydus Healthcare gets CDSCO panel nod for study of Indacaterol, Budesonide inhaler

Zydus Pharmaceuticals Inc, USA had earlier signed a license and supply agreement with CHEMI SpA of Italy, a subsidiary of Italfarmaco Group, to launch the generic equivalent of Sanofi Aventis's branded product Lovenox (Enoxaparin Sodium Injection) in seven dosage strengths in the United States (US). 

Headquartered in Ahmedabad, the company discovers, develops, manufactures, and markets a broad range of healthcare therapies.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News